Total
0
Shares
Dotz Nano (ASX:DTZ) - Chairman and interim CEO, Bernie Brookes
Chairman and interim CEO, Bernie Brookes
Source: Dotz Nano
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Dotz Nano (DTZ) enters a distribution agreement with El Alamo and has already received a US$220,000 (A$300,630) initial purchase order
  • Base in Paraguay, El Alamo is a leading supplier of medical solutions and technologies
  • Under the deal, El Alamo has the right to sell the Dotz test kits in Paraguay with a minimum annual purchase of US$200,000 (A$273,300) in 2021
  • Dotz’s test kits are used to detect the SARS-CoV-2 virus by taking a saliva-based and nasopharyngeal swab with results received in less than 17 minutes
  • Dotz is up 3.66 per cent on the market with shares trading at 42.5 cents at 2:22 pm AEST

Dotz Nano (DTZ) has entered a distribution agreement with El Alamo and has already received a US$220,000 (A$300,630) initial purchase order.

Base in Paraguay, El Alamo is a leading supplier of medical solutions and technologies.

It has more than 20 years’ experience importing, packaging and distributing international medical products in Paraguay.

Under the agreement, El Alamo has the right to sell the Dotz test kits in Paraguay with a minimum annual purchase of US$200,000 (A$273,300) in 2021.

El Alamo must also have a minimum purchase order of US$420,000 (A$573,930) in both 2022 and 2023.

Subject to Dotz’s approval, El Alamo can also appoint sub-distributors and either party can end the agreement with 90 days notice.

This is the second agreement Dotz has entered into for its SARS-CoV-2 virus detection technology, following a signing with Hygiene Links.

Dotz’s test kits are used to detect the SARS-CoV-2 virus by taking a saliva-based and nasopharyngeal swab.

Results are received in less than 17 minutes which makes it a simple, quick and cost-effective test.

Chairman Bernie Brookes commented on the agreement.

“In line with our long term growth strategy, we continue to commercialise our SARS-CoV-2 virus detection technology,” Mr Brookes said.

“Our second distribution agreement within the diagnostic domain cost-effectively increases our global target market while providing public and private facilities with access to an effective and timely testing method.”

Dotz was up 3.66 per cent on the market with shares trading at 42.5 cents at 2:22 pm AEST.

DTZ by the numbers
More From The Market Herald
Biogene Technology (ASX:BGT) - CEO, Richard Jagger

" Bio-Gene Technology (ASX:BGT) executes option agreement with Clarke

Ag-tech company Bio-Gene Technology (BGT) has executed an option agreement with Clarke Mosquito Control.
BrainChip Holdings (ASX:BRN) -

" BrainChip (ASX:BRN) awarded two new US patents

BrainChip (BRN) has been awarded two new patents from the US Patents and Trademarks Office relating to its neuromorphic artificial intelligence chips.
YPB Group (ASX:YPB) - Executive Chairman, John Houston

" Shares in YPB Group (ASX:YPB) soar after e-cigarette contract

YPB Group (YPB) has seen its share price jump 50 per cent after securing a supply contract with electronic cigarette and vaporiser manufacturer

" Vection Technologies (ASX:VR1) embeds app within Webex

Vection Technologies (VR1) has become an embedded app launch partner at the 2021 WebexOne event.